France's Boiron Diversifies Into Probiotics To Arrest Sales Decline
Executive Summary
Homeopathy specialist Boiron its diversifying its offering into the increasingly popular probiotics segment with launches underway in France, Italy and Spain, as well as Eastern Europe.
You may also be interested in...
France's Boiron Strikes Deal With Bionorica As Q3 Sales Edge Up
Boiron has gained the rights to distribute Bionorica's Canephron herbal medicine in France as it continues to diversify its portfolio away from homeopathy.
EU Q1 Sales Round-Up: Karo Pharma, Boiron And Ipsen
Consumer health first-quarter results round-up featuring Karo Pharma, Boiron and Ipsen.
EU Business Round-Up: BioGaia Creates Investment Arm, Boiron Grows In Spain, GSK Ends Hikma Talks
Latest European consumer health business news: BioGaia sets up an investment arm to identify interesting start-ups, France's Boiron expands its Spain offering with Iprad deal, and GSK ends talks with Hikma over the sale of its Egyptian OTC business.